205 related articles for article (PubMed ID: 9842965)
21. Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.
Pearce SH; Trump D; Wooding C; Sheppard MN; Clayton RN; Thakker RV
Clin Endocrinol (Oxf); 1996 Aug; 45(2):195-200. PubMed ID: 8881452
[TBL] [Abstract][Full Text] [Related]
22. Loss of heterozygosity of the BRCA1 and FHIT genes in patients with sporadic breast cancer from Southern Brazil.
Santos SC; Cavalli LR; Cavalli IJ; Lima RS; Haddad BR; Ribeiro EM
J Clin Pathol; 2004 Apr; 57(4):374-7. PubMed ID: 15047740
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2.
Gaffney DK; Hemmersmeier J; Holden J; Marshall J; Smith LM; Avizonis V; Tran T; Neuhausen SL
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):539-46. PubMed ID: 11173152
[TBL] [Abstract][Full Text] [Related]
24. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.
Tirkkonen M; Johannsson O; Agnarsson BA; Olsson H; Ingvarsson S; Karhu R; Tanner M; Isola J; Barkardottir RB; Borg A; Kallioniemi OP
Cancer Res; 1997 Apr; 57(7):1222-7. PubMed ID: 9102202
[TBL] [Abstract][Full Text] [Related]
25. Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions.
Lin YW; Sheu JC; Liu LY; Chen CH; Lee HS; Huang GT; Wang JT; Lee PH; Lu FJ
Eur J Cancer; 1999 Nov; 35(12):1730-4. PubMed ID: 10674021
[TBL] [Abstract][Full Text] [Related]
26. Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumors.
Plummer SJ; Paris MJ; Myles J; Tubbs R; Crowe J; Casey G
Genes Chromosomes Cancer; 1997 Dec; 20(4):354-62. PubMed ID: 9408751
[TBL] [Abstract][Full Text] [Related]
27. Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors.
Johannsdottir HK; Jonsson G; Johannesdottir G; Agnarsson BA; Eerola H; Arason A; Heikkila P; Egilsson V; Olsson H; Johannsson OT; Nevanlinna H; Borg A; Barkardottir RB
Int J Cancer; 2006 Sep; 119(5):1052-60. PubMed ID: 16570289
[TBL] [Abstract][Full Text] [Related]
28. A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1.
Godwin AK; Vanderveer L; Schultz DC; Lynch HT; Altomare DA; Buetow KH; Daly M; Getts LA; Masny A; Rosenblum N
Am J Hum Genet; 1994 Oct; 55(4):666-77. PubMed ID: 7942844
[TBL] [Abstract][Full Text] [Related]
29. BRCA1 and BRCA2 in breast cancer.
Yang X; Lippman ME
Breast Cancer Res Treat; 1999 Mar; 54(1):1-10. PubMed ID: 10369075
[TBL] [Abstract][Full Text] [Related]
30. Sporadic breast cancer in young women: prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2.
Johnson SM; Shaw JA; Walker RA
Int J Cancer; 2002 Mar; 98(2):205-9. PubMed ID: 11857409
[TBL] [Abstract][Full Text] [Related]
31. Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors.
Gras E; Cortes J; Diez O; Alonso C; Matias-Guiu X; Baiget M; Prat J
Cancer; 2001 Aug; 92(4):787-95. PubMed ID: 11550149
[TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.
Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR
Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281
[TBL] [Abstract][Full Text] [Related]
33. Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma.
Schmutzler RK; Bierhoff E; Werkhausen T; Fimmers R; Speiser P; Kubista E; Krebs D; Zeillinger R; Wiestler OD; Von Deimling A
Int J Cancer; 1997 Jun; 74(3):322-5. PubMed ID: 9221812
[TBL] [Abstract][Full Text] [Related]
34. Loss of heterozygosity (LOH) at p53 is correlated with LOH at BRCA1 and BRCA2 in various human malignant tumors.
Tong D; Kucera E; Schuster E; Schmutzler RK; Swoboda H; Reinthaller A; Leodolter S; Zeillinger R
Int J Cancer; 2000 Oct; 88(2):319-22. PubMed ID: 11004687
[No Abstract] [Full Text] [Related]
35. Loss of heterozygosity analysis in ductal lavage samples from BRCA1 and BRCA2 carriers: a cautionary tale.
Antill YC; Mitchell G; Johnson SA; Devereux L; Milner A; Phillips KA; Campbell IG
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1396-8. PubMed ID: 16835342
[TBL] [Abstract][Full Text] [Related]
36. Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer.
Hamann U; Herbold C; Costa S; Solomayer EF; Kaufmann M; Bastert G; Ulmer HU; Frenzel H; Komitowski D
Cancer Res; 1996 May; 56(9):1988-90. PubMed ID: 8616837
[TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
[TBL] [Abstract][Full Text] [Related]
38. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.
Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A
Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424
[TBL] [Abstract][Full Text] [Related]
39. Somatic mutations in the BRCA2 gene and high frequency of allelic loss of BRCA2 in sporadic male breast cancer.
Kwiatkowska E; Teresiak M; Breborowicz D; Mackiewicz A
Int J Cancer; 2002 Apr; 98(6):943-5. PubMed ID: 11948477
[TBL] [Abstract][Full Text] [Related]
40. Lack of BRCA2 alterations in primary head and neck squamous cell carcinoma.
Nawroz-Danish HM; Koch WM; Westra WH; Yoo G; Sidransky D
Otolaryngol Head Neck Surg; 1998 Jul; 119(1):21-5. PubMed ID: 9674510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
